BEGIN:VCALENDAR
VERSION:2.0
PRODID:-// - ECPv4.7.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.mdtechcouncil.com/membership/events
X-WR-CALDESC:Events for 
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240313T110000
DTEND;TZID=America/New_York:20240313T120000
DTSTAMP:20260418T043504
CREATED:20240301T163943Z
LAST-MODIFIED:20240301T163943Z
UID:4433-1710327600-1710331200@www.mdtechcouncil.com
SUMMARY:NIH Technology Opportunity Webinar: An Adjuvanted Mucosal Subunit Vaccine for Preventing SARS-CoV-2 Transmission and Infection
DESCRIPTION:Register to attend a free NIH webinar. Attendees will learn about a new adjuvanted subunit mucosal COVID-19 vaccine. Study results show this new vaccine prevents SARS-CoV-2 transmission and infection. Most SARS-CoV-2 vaccines focus on delivering immunization through an intramuscular injection. This new technology combines an initial intramuscular injection with subsequent intranasal boost administration of a novel\, molecular adjuvant nanoparticle formulation. \nThe inventors will discuss this new intranasal vaccine formulation\, the combined intramuscular prime and intranasal boost methodology\, and results from applying this method for treating and preventing SARS-CoV-2 transmission and infection. \nThe NCI is looking for a collaboration/licensing partner to assist with further development of this technology\, ultimately leading to a clinical trial and/or take on commercial development. \n
URL:https://www.mdtechcouncil.com/membership/events/calendar/nih-technology-opportunity-webinar-an-adjuvanted-mucosal-subunit-vaccine-for-preventing-sars-cov-2-transmission-and-infection/
LOCATION:Virtual Event
ORGANIZER;CN="NIH%7CNCI%20Tech%20Transfer%20Center":MAILTO:rouault@mail.nih.gov
END:VEVENT
END:VCALENDAR